Zhejiang Anglikang Pharmaceutical Co., Ltd.

This early-phase trial tests a new drug called ALK-N001 in 16 adults with advanced solid tumors (like esophageal, lung, or stomach cancer) that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it helps contr…